Global 500 2022
Typography by Sergi Delgado

Company Information

As of 3/29/23
Country
U.S.
Headquarters
New York City
Industry
Pharmaceuticals
CEO
Albert Bourla
Company Type
Public
Ticker
PFE
Revenues ($M)
$100,330
Profits ($M)
$31,372
Market Value ($M)
$225,437
Employees
83,000
Figures are for fiscal year ended Dec. 31, 2022. Market value as of March 8, 2023. Sources: S&P Global; Bloomberg.

Key Financials (Last Fiscal Year)
As of 8/3/2022

($ Millions)
% change
Revenues ($M)
$81,288
94%
Profits ($M)
$21,979
128.6%
Assets ($M)
$181,476
-
Total Stockholder Equity ($M)
$77,201
-

Profit Ratios
As of 8/3/2022

Profit as % of Revenues
27%
Profits as % of Assets
12.1%
Profits as % of Stockholder Equity
28.5%

Pfizer Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$41,908-19%$9,616-40.9%$154,229$63,238
2020$51,750-3.5%$16,27345.9%$167,489$63,143
2019$53,6472.1%$11,153-47.7%$159,422$63,407
2018$52,546-0.5%$21,308195.3%$171,797$71,308
2017$52,8248.1%$7,2153.7%$171,615$59,544
SHOW MORE
FortuneDataStore ad
Lists ranking Pfizer
RANK137
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE
RANK43
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK8
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE
RANK38
America's Most Innovative Companies - 2023The 300 companies on this list are transforming in...READ MORE